Cargando…

Ferumoxytol across the age spectrum: a single center experience of safety

Detalles Bibliográficos
Autores principales:	Nguyen, Kim-Lien, Yoshida, Takegawa, Ayad, Ihab, Reemtsen, Brian, Satou, Gary M, Hu, Peng, Salusky, Isidro, Finn, J Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032529/ http://dx.doi.org/10.1186/1532-429X-18-S1-P259

Ejemplares similares

MRI with ferumoxytol: A single center experience of safety across the age spectrum
por: Nguyen, Kim‐Lien, et al.
Publicado: (2016)

Ferumoxytol MR angiography for pre-TAVR assessment
por: Finn, J Paul, et al.
Publicado: (2016)

4D Multiphase steady state imaging with contrast (MUSIC) enhancement using ferumoxytol: a new paradigm in pediatric congenital heart disease
por: Nguyen, Kim-Lien, et al.
Publicado: (2016)

Ferumoxytole-enhanced 4D MR angiography with retrospectively defined temporal resolution
por: Zhou, Ziwu, et al.
Publicado: (2016)

Ferumoxytol MRA and non-contrast CT fusion in TAVR candidates with renal failure
por: Yoshida, Takegawa, et al.
Publicado: (2016)

Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging
por: Nguyen, Kim-Lien, et al.
Publicado: (2017)

CMR in pediatric patients with congenital heart disease: comparison at 1.5T and at 3.0T
por: Nguyen, Kim-Lien, et al.
Publicado: (2012)

4-dimensional, multiphase, steady-state imaging with contrast enhancement (MUSIC) in the heart; a feasibility study in children
por: Han, Fei, et al.
Publicado: (2015)

Ferumoxytol-enhanced 4D multiphase, steady-state imaging with magnetic resonance in congenital heart disease: ventricular volume and function across 2D and 3D software platforms
por: Yoshida, Takegawa, et al.
Publicado: (2022)

The ferumoxytol in renal insufficiency study (FiRST)
por: Vemulapalli, Sreekanth, et al.
Publicado: (2013)

High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion
por: Shahrouki, Puja, et al.
Publicado: (2019)

4D MUSIC CMR: value-based imaging of neonates and infants with congenital heart disease
por: Nguyen, Kim-Lien, et al.
Publicado: (2017)

Measurement of myocardial blood volume and water exchange using ferumoxytol
por: Chatterjee, Neil, et al.
Publicado: (2015)

Contemporary sequential segmental approach to congenital heart disease using four-dimensional magnetic resonance imaging with ferumoxytol: an illustrated editorial
por: Yoo, Shi-Joon, et al.
Publicado: (2023)

Improved 2D slice-interleaved flow-independent cardiac black blood imaging using Ferumoxytol
por: Lu, Junfei, et al.
Publicado: (2015)

Detection of acute myocardial infarct with T1-mapping post ferumoxytol contrast administration
por: Spatz, Deneen, et al.
Publicado: (2013)

Cost benefits of cardiovascular magnetic resonance imaging and angiography performed earlier in the diagnostic assessment of neonatal complex congenital heart disease
por: Renella, Pierangelo, et al.
Publicado: (2014)

Time course of the effect of ferumoxytol on T1-relaxation times of blood, liver, myocardium, and acute infarction
por: Spatz, Deneen, et al.
Publicado: (2012)

High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol
por: Shahrouki, Puja, et al.
Publicado: (2021)

Ferumoxytol-Enhanced Cardiac Magnetic Resonance Angiography and 4D Flow: Safety and Utility in Pediatric and Adult Congenital Heart Disease
por: Renella, Pierangelo, et al.
Publicado: (2022)

Cardiac and respiratory self-gated 4D multi-phase steady-state imaging with ferumoxytol contrast (MUSIC)
por: Han, Fei, et al.
Publicado: (2016)

Measurement of myocardial blood volume and water exchange using ferumoxytol
por: Chatterjee, Neil, et al.
Publicado: (2015)

T1 mapping across the ejection fraction spectrum
por: Alaour, Bashir, et al.
Publicado: (2016)

Imaging Tumor Necrosis with Ferumoxytol
por: Aghighi, Maryam, et al.
Publicado: (2015)

Population Pharmacokinetic Meta-Analysis to Bridge Ferumoxytol Plasma Pharmacokinetics Across Populations
por: Plock, Nele, et al.
Publicado: (2014)

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
por: Vadhan-Raj, Saroj, et al.
Publicado: (2017)

High-field MR imaging in pediatric congenital heart disease: Initial results
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Safety and efficacy of a single total dose infusion (1020 mg) of ferumoxytol
por: Khan, Harris, et al.
Publicado: (2021)

Cardiac MR imaging and MR angiography in pediatric congenital heart disease: a comparison between 1.5T and 3.0T
por: Nguyen, KL, et al.
Publicado: (2013)

Survey proportion of safety and ergonomics parameters in Sabzevar preschool centers
por: Abareshi, Fateme, et al.
Publicado: (2019)

CMR Clinical Practice Patterns Across Four U.S. Medical Centers from 2010-2014
por: Shah, Dipan J, et al.
Publicado: (2016)

P342: Patient safety and risk management in health center in Niger
por: Djibo, H, et al.
Publicado: (2013)

Safety assessment of the direct sequence spread spectrum wireless local area network with a medical device
por: Loh, T, et al.
Publicado: (2008)

CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)
por: Khan, SN, et al.
Publicado: (2013)

P04.16. Integrative medicine practice patterns across the US: results from a survey of 29 centers
por: Abrams, D, et al.
Publicado: (2012)

Patient’s safety culture among health care professionals in Tunisian Center-Est University Hospital
por: Bouafia, N, et al.
Publicado: (2015)

Acute effects of ferumoxytol on regulation of renal hemodynamics and oxygenation
por: Cantow, Kathleen, et al.
Publicado: (2016)

Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis
por: Stirrat, Colin G, et al.
Publicado: (2018)

Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation
por: Stirrat, Colin G, et al.
Publicado: (2019)

The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pt3rhn1avplff27oakh9211ut0